Original publications

  • TM Stulnig: The ZONE Diet and Metabolic Control in Type 2 Diabetes. Journal of the American College of Nutrition, 34:39-41 (2015)

  • L Leitner, K Schuch, A Jürets, BK Itariu, M Keck, V Grablowitz, OC Aszmann, G Prager, G Staffler, M Zeyda, TM Stulnig: Immunological blockade of adipocyte inflammation caused by increased matrix metalloproteinase-cleaved osteopontin in obesity. Obesity, 23:779-785 (2015)

  • Y Winhofer, M Krssak, P Wolf, CH Anderwald, A Geroldinger, G Heinze, S Baumgartner-Parzer, R Marculescu, TM Stulnig, M Wolzt, S Trattnig, A Luger, M Krebs: Free fatty acid availability is closely related to myocardial lipid storage and cardiac function in hypoglycemia counter-regulation. Am J Physiol, Endocrin and Metab, 308:E631-E640 (2015)

  • S Moosheer, W Waldschütz, BK Itariu, H Brath, TM Stulnig: A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Primary Care Diabetes, 8:308-314 (2014)

  • D Weghuber, H Mangge, EE Hochbrugger, TM Stulnig: Impact of Age and Metabolic Syndrome on the Adipokine Profile in Childhood and Adult Obesity. Exp Clin Endocrinol Diabetes, 122:363-367 (2014)

  • A Neuhofer, B Wernly, L Leitner, A Sarabi, NG Sommer, G Staffler, M Zeyda, TM Stulnig: An accelerated mouse model for atherosclerosis and adipose tissue inflammation. Cardiovasc Diabetol, 13:23-32 (2014)

  • S Moosheer, W Waldschütz, BK Itariu, H Brath, TM Stulnig: A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Primary Care Diab 8:308-314 (2014)

  • BK Itariu, M Zeyda, G Prager, TM Stulnig: Insulin-like growth factor-1 predicts post-load hypoglycemia following bariatric surgery: a prospective cohort study. Plos ONE, doi:10.1371/journal.pone.0094613

  • A Fenzl, BK Itariu, L Kosi, M Fritzer-Szekeres, A Kautzky-Willer, TM Stulnig, FW Kiefer: Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 57:1204-1208 (2014)

  • M Keck, J Kober, O Riedl, HB Kitzinger, S Wolf, TM Stulnig, M Zeyda, A Gugerell: Power assisted liposcuction to obtain adipose-derived stem cells: impact on viability and differentiation to adipocytes in comparison to manual aspiration. The Journal of Plastic, Reconstructive & Aesthetic Surgery 67:e1-e8 (2014).

  • J Lindroos, J Husa, G Mitterer, A Haschemi, S Rauscher, R Haas, M Gröger, R Loewe, N Kohrgruber, KF Schrögendorfer, G Prager, H Beck, JA Pospisilik, M Zeyda, TM Stulnig, W Patsch, O Wagner, H Esterbauer, M Bilban: Human but Not Mouse Adipogenesis Is Critically Dependent on LMO3. Cell Metabolism 18:62-74 (2013).
  • BK Itariu, L Leitner, R Marculescu, M Zeyda, TM Stulnig: Treatment with n-3 polyunsaturated fatty acid for eight weeks does not influence vitamin D status in severely obese subjects. PLOS ONE 8:e54634- (2013) 
  • M Rohm, A Sommerfeld, D Strzoda, A Jones, G Rudofsky, C Wolfrum, C Sticht, N Gretz, M Zeyda, L Leitner, P Nawroth, TM Stulnig, A Vgiopoulos, S Herzig: Transcriptional co-factor TBLR1 controls lipid mobilization in white adipose tissue. Cell Metabolism 17:575-585 (2013).
  • A Neuhofer, M Zeyda, D Mascher, BK Itariu, I Murano, L Leitner, EE Hochbrugger, P Fraisl, S Cinti, CN Serhan, TM Stulnig: Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation. Diabetes 62:1945-1956 (2013).
  • S Sigel, S Bunk, T Meergans, B Doninger, K Stich, T Stulnig, K Derfler, J Hoffmann, S Deininger, S von Aulock, S Knapp: Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune responses in humans and mice. Eur J Immunol 42:2983-2989 (2012). 
  • BK Itariu, M Zeyda, EE Hochbrugger, A Neuhofer, G Prager, K Schindler, A Bohdjalian, D Mascher, S Vangala, M Schranz, M Krebs, MG Bischof, TM Stulnig: Long-chain n-3 polyunsaturated fatty acis reduce adipose tissue and systemic inflammation in severely obese non-diabetic patients – a randomized controlled trial. Amer J Clin Nutr 96:1137-1149 (2012). 
  • Y Winhofer, FW Kiefer, A Handisurya, A Tura, K Klein, B Schneider, R Marculescu, OF Wagner, G Pacini, A Luger, TM Stulnig, A Kautzky-Willer: CTX (crosslaps) rather than osteopontin is associated with disturbed glucose metabolism in gestational diabetes. PLoS ONE 7:e40947- (2012). 
  • M Zeyda, B Wernly, S Demyanets, C Kaun, M Hämmerle, B Hantusch, A Neuhofer, B Itariu, M Keck, G Prager, J Wojta, TM Stulnig: The expression of interleukin-33 and its receptor ST2 is increased in obesity and both predominantly found in endothelial cells of human adipose tissue. Int J Obeseity published ahead online 10.1038/ijo.2012.118 ijo2012118 [pii] :- (2012). 
  • FW Kiefer, C Vernochet, P O'Brian, S Spoerl, JD Brown, M Zeyda, TM Stulnig, TE Gundersen, DE Cohen, CR Kahn, J Plutzky: Retinaldehyde dehydrogenase 1 is a novel regulator of adaptive thermogenesis in white adipose tissue. Nat Med 18:918-925 (2012). 
  • M Keck, M Zeyda, S Burjak, LP Kamolz, H Selig, TM Stulnig, M Frey: Coenzyme Q10 does not enhance preadipocyte viability in an in vitro lipotransfer model. Aesthetic Plast Surg 36:453-457 (2012). 
  • J Patsch, FW Kiefer, P Varga, P Pail, M Rauner, D Stupphann, H Resch, D Moser, PK Zysset, TM Stulnig, P Pietschmann: Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet–induced obesity. Metabolism Clin Exp 60:243-249 (2011). 
  • M Zeyda, J Huber, G Prager, TM Stulnig: Inflammation correlates with markers of T cell subsets including regulatory T cells in adipose tissue from obese patients. Obesity 19:743-748 (2011).  
  • M Zeyda, K Gollinger, J Todoric, F Kiefer, M Keck, O Aszmann, G Prager, G Zlabinger, TM Stulnig: Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function. Endocrinology 152:2219-2227 (2011). 
  • FW Kiefer, S Neschen, B Pfau, B Legerer, A neuhofer, M Kahle, M Hrabe de Angelis, M Schlederer, M Mair, L Kenner, J Plutzky, M Zeyda TM Stulnig: Osteopontin deficiency protects from obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 54:2132-2142 (2011).  
top